Aura is developing an innovative therapy for ocular melanoma and other eye cancers based on a new viral nanoparticle technology that targets malignant cells without affecting healthy tissue. This is potentially the first true alternative to current invasive and often imprecise and toxic treatments for these types of cancers.
CEO
Elisabet de los Pinos
WEBSITE
https://aurabiosciences.com/
INVESTED COMPANY
2016
DETAILS
Aura Biosciences, Inc.
85 Bolton Street
Cambridge, MA 02140, USA
